نتائج البحث - "Mathew Simcock"

المصدر: European journal of cancer (Oxford, England : 1990)
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname

مصطلحات موضوعية: Male, 0301 basic medicine, Cancer Research, Time Factors, Gastroenterology, nab-paclitaxel, Neuroblastoma, 0302 clinical medicine, Neoplasms, Rhabdomyosarcoma, 1306 Cancer Research, Drug Dosage Calculations, Child, Leukopenia, Not Otherwise Specified, Age Factors, Metastatic breast cancer, Europe, Treatment Outcome, Oncology, Tolerability, Paediatric, Child, Preschool, 030220 oncology & carcinogenesis, 2730 Oncology, Female, Sarcoma, medicine.symptom, Canada, medicine.medical_specialty, Adolescent, Maximum Tolerated Dose, Paclitaxel, 610 Medicine & health, Ewing sarcoma, Solid tumour, Neutropenia, Drug Administration Schedule, 03 medical and health sciences, Refractory, Albumins, Internal medicine, medicine, Humans, business.industry, medicine.disease, Antineoplastic Agents, Phytogenic, United States, 030104 developmental biology, 10036 Medical Clinic, business, Ewing sarcoma, Neuroblastoma, Paediatric, Rhabdomyosarcoma, Solid tumour, nab-paclitaxel

وصف الملف: PIIS0959804918308426.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::156a3273c98b1be9bcf090af25de73ccTest
https://doi.org/10.1016/j.ejca.2018.05.002Test

8

Response to upfront azacitidine in juvenile myelomonocytic leukemia in the AZA-JMML-001 trial

المصدر: blood advances
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
Blood Adv

مصطلحات موضوعية: 0301 basic medicine, Adult, medicine.medical_specialty, Clinical Trials and Observations, medicine.medical_treatment, Azacitidine, Population, Hematopoietic stem cell transplantation, 03 medical and health sciences, 0302 clinical medicine, Pharmacokinetics, Internal medicine, medicine, Clinical endpoint, Humans, ddc:610, education, Child, JMML, education.field_of_study, Juvenile myelomonocytic leukemia, business.industry, Hematopoietic Stem Cell Transplantation, Hematology, DNA Methylation, medicine.disease, Leukemia, 030104 developmental biology, Leukemia, Myelomonocytic, Juvenile, Settore MED/38 - PEDIATRIA GENERALE E SPECIALISTICA, 030220 oncology & carcinogenesis, Mutation, business, Progressive disease, medicine.drug

وصف الملف: application/octet-stream

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93a538bf92eb9e760b7d3460e448e13cTest
https://hdl.handle.net/10807/229230Test

9

Phase II results from a phase I/II study to assess the safety and efficacy of weekly nab-paclitaxel in paediatric patients with recurrent or refractory solid tumours: A collaboration with the European Innovative Therapies for Children with Cancer Network

المؤلفون: Gianni Bisogno, Nicolas U. Gerber, Gilles Vassal, Nianhang Chen, François Doz, Lucas Moreno, Victoria Castel, Mathew Simcock, Soledad Gallego Melcon, Franca Fagioli, Pooja Hingorani, Antonio Ruggiero, Yvan Le Bruchec, Julia C. Chisholm, Michela Casanova, Ruta Slepetis, Catalina Marquez-Vega, Loredana Amoroso

المساهمون: University of Zurich, Amoroso, Loredana

المصدر: European journal of cancer (Oxford, England : 1990)
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname

مصطلحات موضوعية: 0301 basic medicine, Male, Cancer Research, Time Factors, Phases of clinical research, Gastroenterology, chemistry.chemical_compound, Neuroblastoma, 0302 clinical medicine, Rhabdomyosarcoma, Medicine, Tissue Distribution, 1306 Cancer Research, Child, Albumin-bound paclitaxel, Age Factors, Progression-Free Survival, Europe, Settore MED/38 - PEDIATRIA GENERALE E SPECIALISTICA, Oncology, Tolerability, Paclitaxel, Paediatric, 030220 oncology & carcinogenesis, Child, Preschool, Female, 2730 Oncology, Sarcoma, medicine.medical_specialty, Adolescent, Bone Neoplasms, 610 Medicine & health, Solid tumour, Sarcoma, Ewing, Neutropenia, Drug Administration Schedule, 03 medical and health sciences, Young Adult, Refractory, Internal medicine, Albumins, Humans, Progression-free survival, business.industry, Infant, medicine.disease, Antineoplastic Agents, Phytogenic, 030104 developmental biology, Ewing sarcoma, chemistry, 10036 Medical Clinic, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41dfac6e33f3800a35fd346c2d569076Test
https://www.zora.uzh.ch/id/eprint/197971Test/

10

DataSheet_1_Phase 2 Study of Pomalidomide (CC-4047) Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain Tumors.pdf

المؤلفون: Jason Fangusaro (10940634), Maria Giuseppina Cefalo (10940637), Maria Luisa Garré (10940640), Lynley V. Marshall (7826822), Maura Massimino (4112107), Bouchra Benettaib (10940643), Noha Biserna (10940646), Jennifer Poon (10940649), Jackie Quan (10940652), Erin Conlin (10940655), John Lewandowski (685018), Mathew Simcock (274173), Neelum Jeste (10940658), Darren R. Hargrave (10940661), François Doz (2541151), Katherine E. Warren (10940664)

مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, diffuse intrinsic pontine glioma, ependymoma, high-grade glioma, medulloblastoma, pomalidomide, progressive or recurrent disease

العلاقة: https://figshare.com/articles/dataset/DataSheet_1_Phase_2_Study_of_Pomalidomide_CC-4047_Monotherapy_for_Children_and_Young_Adults_With_Recurrent_or_Progressive_Primary_Brain_Tumors_pdf/14748708Test

الإتاحة: https://doi.org/10.3389/fonc.2021.660892.s001Test

View record in BASE

تنقيح النتائج